SLC39A1 is negatively correlated with NK cell activation and monocytes in gliomas and B‐cell immunity in Pan‐Cancer, contributing to tumour immune evasion and NK cell‐mediated cytotoxicity suppression.29 This evidence concerns the gene SLC39A1 and central nervous system cancer.